MMM

MODUS THERAPEUTICS HOLDING AB

No trades
See on Supercharts

MODTX fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Modus Therapeutics Holding AB operates as a biotechnology company. It develops sevuparin with a focus on diseases with a high unmet medical need. The firm focuses to develop sevuparin for patients with sepsis / septic shock, which is a serious and often fatal condition. The company was founded in 2011 and is headquartered in Stockholm, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

MODTX does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company